Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium

Human Psychopharmacology

Volumn 26, Issue 2, 2011, Pages 95-101

  Wang, Yiming ^a,b   Xiao, Zhengjun ^a,c   Liu, Xingde ^a   Berk, Michael ^b,d,e  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

apoptotic genes; chronic mild stress; hippocampus; major depressive disorder; myocardium; venlafaxine

Indexed keywords

MESSENGER RNA; PROTEIN BAX; PROTEIN BCL XL; SUCROSE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR CHANGE; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DOWN REGULATION; GENE EXPRESSION; HEART MUSCLE; HIPPOCAMPUS; MAJOR DEPRESSION; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UPREGULATION;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CYCLOHEXANOLS; DEPRESSION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MYOCARDIUM; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STRESS, PSYCHOLOGICAL;

EID: 79956265515     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1177     Document Type: Review

References (58)

1. Aan het Rot M, Mathew SJ, Charney DS,. 2009. Neurobiological mechanisms in major depressive disorder. Can Med Assoc J 180: 305-313.
2. Alme MN, Wibrand K, Dagestad G, Bramham CR,. 2007. Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast 2007: 1-9.
3. Augustyn M, Otczyk M, Budziszewska B, et al,. 2005. Effects of some new antidepressant drugs on the glucocorticoid receptor-mediated gene transcription in fibroblast cells. Pharmacol Rep 57: 766-773.
4. Berger G, Dell'Olio M, Amminger P, et al,. 2007. Neuroprotection in emerging psychotic disorders. Early Interv Psychiatry 1: 114-127.
5. Bergström A, Jayatissa MN, ThykjÃ∥r T, Wiborg O,. 2007. Molecular pathways associated with stress resilienc and drug resistance in the chronic mild stress rat model of depression-a gene expression study. J Mol Neurosci 33: 201-215. (Pubitemid 47574943)
6. Berk M,. 2009. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 12: 441-445.
7. Berk M, Conus P, Kapczinski F, et al,. 2010. From neuroprogression to neuroprotection: implications for clinical care. MJA 193: S36-S40.
8. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME,. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription- dependent and independent mechanisms. Science 286: 1358-1362.
9. Carney RM, Saunders RD, Freedland KE, Stein P, Rich MW, Jaffe AS,. 1995. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 76: 562-564.
10. Chang JS, Hsu YL, Kuo PL, Kuo YC, Chianga LC, Lin CC,. 2005. Increase of Bax/Bcl-XL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci 76: 1883-1893.
11. Cory S, Huang DC, Adams JM,. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607. (Pubitemid 38028528)
12. Czubak A, Nowakowska E, Kus K, et al,. 2009. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep 61: 1017-1023.
13. D'Aquila PS, Brain PF, Willner P,. 1994. Effects of chronic mild stress in behavioural tests relevant to anxiety and depression. Physiol Behav 56: 861-867. (Pubitemid 24337098)
14. Deckwerth TL, Elliott JL, Knudson CM, Johnson EM, Jr, Snider WD, Korsmeyer SJ,. 1996. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17: 401-411. (Pubitemid 26322212)
15. Dwivedi Y, Rizavi HS, Pandey GN,. 2006. Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139: 1017-1029.
16. Erdodan F, Golgeli A, Arman F, Ersoy AO,. 2004. The effects of pentylenetetrazole induced status epilepticus on behavior, emotional memory and learning in rats. Epilepsy Behav 5: 388-393. (Pubitemid 38950099)
17. Eren I, Nazroglu M, Demirdas A, Celik OA, Uguz AC, Altunbasak A,. 2007. Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res 32: 497-505. (Pubitemid 46295149)
18. Ghosh A, Carnahan J, Greenberg ME,. 1994. Requirement for BDNF in activity dependent survival of cortical neurons. Science 263: 1618-1623. (Pubitemid 24128367)
19. Grippo AJ, Beltz TG, Johnson AK,. 2003. Behavioral and cardiovascular changes in the chronic mild stress model of depression. Physiol Behav 78: 703-710. (Pubitemid 36628099)
20. Grippo AJ, Beltz TG, Weiss RM, Johnson AK,. 2006. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry 59: 309-316. (Pubitemid 43238355)
21. Heim C, Nemeroff CB,. 2001. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49: 1023-1039. (Pubitemid 32595461)
22. Heim C, Newport DJ, Wagner D, Wilcox MM, Miller AHY, Nemeroff CB,. 2002. The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women:a multiple repression analysis. Depress Anxiety 15: 117-125. (Pubitemid 34522472)
23. Henningsen K, Andreasen JT, Bouzinova EV, et al,. 2009. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic like responses. Behav Brain Res 198: 136-141.
24. Ho YL, Chen CL, Hsu RB, Lin LC, Huang PJ,. 2003. The correlation between expression of apoptosis-related proteins and myocardial functional reserve evaluated by dobutamine stress echocardiography in patients with dilated cardiomyopathy. J Am Soc Echocardiogr 16: 931-936.
25. Holm MM, Nieto-Gonzalez JL, Vardya I, et al,. 2010. Hippocampal GABAergic dysfunction in a rat chronic mild stress model of depression. Hippocampus 19: 1-12.
26. Huang EJ, Reichardt LF,. 2001. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736. (Pubitemid 32695243)
27. Joels M, Karst H, Alfarez D, et al,. 2004. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 7: 221-231. (Pubitemid 40591422)
28. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T,. 1995. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92: 8856-8860.
29. Kosten TA, Galloway MP, Duman RS, Russell DS, D'Sa C,. 2008. Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 33: 1545-1558. (Pubitemid 351684697)
30. Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C,. 2010. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res 44: 808-816.
31. Li S, Wang C, Wang W, Dong H, Hou P, Tang Y,. 2008. Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior. Life Sci 82: 934-942.
32. Maes M, Galecki P, Chang YS, Berk M,. 2010. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 12 [Epub ahead of print].
33. Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M,. 2010. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 16 [Epub ahead of print].
34. Magarinos AM, McEwen BS,. 1995. Stress-induced atrophy of apical dendrites of hippocampal CA3 neurons:comparison of stressors. Neuroscience 69: 83-88.
35. Mata J, Thompson RJ, Gotlib IH,. 2010. BDNF genotype moderates the relation between physical activity and depressive symptoms. J Health Psychol 29: 130-133.
36. McAllister AK, Katz LC, Lo DC,. 1999. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 22: 295-318. (Pubitemid 29144890)
37. Mcconnell S, Jacka FN, Williams LJ, Dodd S, Berk M,. 2005. The relationship between depression and cardiovascular disease. Int J Psychiatr Clin Pract 9: 157-167. (Pubitemid 41499383)
38. McKernan DP, Dinan TG, Cryan JF,. 2009. " Killing the blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response? Prog Neurobiol 88: 246-263.
39. Mechan AO, Moran PM, Elliott M, Young AJ, Joseph MH, Green R,. 2002. A study of the effect of a single neurotoxic dose of 3,4- methylenedioxymethamphetamine (MDMA; 'ecstasy') on the subsequent long-term behaviour of rats in the plus maze and open field. Psychopharmacology 159: 167-175. (Pubitemid 34146560)
40. Moreau JL, Jenck F, Martin JR, Mortas P, Haefely WE,. 1992. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats. Eur Neuropsychopharmacol 2: 43-49.
41. Murray M, Kim D, Liu Y, Tobias C, Tessler A, Fischer I,. 2002. Transplantation of genetically modified cells contributes to repair and recovery from spinal injury. Brain Res 40: 292-300. (Pubitemid 36183178)
42. Pasco JA, Kotowicz MA, Henry MJ, et al,. 2006. High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 296: 1353-1355. (Pubitemid 44427419)
43. Pasco JA, Nicholson GC, Ng F, et al,. 2008. Oxidative stress may be a common mechanism linking major depression and osteoporosis. Acta Neuropsychiatr 20: 112-116. (Pubitemid 351724924)
44. Pasco JA, Jacka FN, Williams LJ, et al,. 2010. Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. Psychother Psychosom 79: 323-325.
45. Patterson SL, Abel T, Deuel TA, Martin KC, Rose JC, Kandel ER,. 1996. Recombinant BDNF rescues deficits in basal synaptic transmission in hippocampal LTP in BDNF knockout mice. Neuron 16: 1137-1145. (Pubitemid 26227235)
46. Radecki DT, Brown LM, Martinez J, Teyler TJ,. 2005. BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15: 246-253. (Pubitemid 40458423)
47. Sibille E, Wang Y, Joeyen-Waldorf J, et al,. 2009. A molecular signature of depression in the amygdala. Am J Psychiatry 166: 1011-1024.
48. Strekalova T, Spanagel R, Bartsch D, Henn FA, Gass P,. 2004. Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharmacology 29: 2007-2017. (Pubitemid 39486552)
49. Tebartz van Elst L, Ebert D, Trimble MR,. 2001. Hippocampus and amygdala pathology in depression [letter]. Am J Psychiatry 158: 652-653. (Pubitemid 32289839)
50. Tvrdeic A, Kocevski D,. 2008. Does behavioral response to novelty influence paw withdrawal latencies in repeated Hargreaves test. Period Biol 110: 95-100. (Pubitemid 351578524)
51. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J,. 1997. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 124: 1239-1249. (Pubitemid 27142077)
52. Wann BP, Boucher M, Kaloustian S, Nim S, Godbout R, Rousseau G,. 2006. Apoptosis detected in the amygdala following myocardial infarction in the rat. Biol Psychiatry 59: 430-433. (Pubitemid 43289222)
53. Williams LJ, Jacka FN, Pasco JA, Dodd S, Berk M,. 2006. Depression and pain: an over view. Acta Neuropsychiatr 18: 79-87.
54. Williams LJ, Pasco JA, Jacka FN, Henry MJ, Dodd S, Berk M,. 2009. Depression and bone metabolism. A review. Psychother Psychosom 78: 16-25.
55. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R,. 1987. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology 93: 358-364. (Pubitemid 17160661)
56. Willner P, Muscat R, Papp M,. 1992. Chronic mild stress-induced anhedonia: are alistic animals model of depression. Neurosci Biobehav Rev 16: 525-534.
57. Xu B, Zang K, Ruff NL, et al,. 2000. Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. Neuron 26: 233-245.
58. Yin YY, Li CY, Kan HW, Zheng LF, Ming L,. 2007. Effects of BCPT on the expressions of cerebral cortex BDNF and Bax and the ultra structure of hippocampus of rats treated with chronic unpredictable stress. Chinese Pharmacol Bull 23: 930-934.